Insider trade

CFO sold ~$201K of COLL shares in the open market

Traded Nov 6, 2025 · Filed Nov 7, 2025

Why it stands out

The CFO of Collegium Pharmaceutical sold $201K of Collegium Pharmaceutical shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$200,517

Shares × reported transaction price

Timing vs results

on the day of results (Nov 6, 2025), 112 days before results of Feb 26, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+4.2%	−2.3%	+6.5%
30 days	+12.2%	+0.9%	+11.3%
90 days	+6.3%	+1.8%	+4.5%
180 days	−17.7%	+8.5%	−26.2%

Past results only. Not a forecast.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.75, inclusive.